Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-Blinded, Active-Controlled, Phase II Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

NCT05182034 is registered in ClinicalTrials.gov with Medipost Co Ltd. as lead sponsor.

NCT NCT05182034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05182034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-Blinded, Active-Controlled, Phase II Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis
Lead sponsor
Medipost Co Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 24, 2022
Completion date
October 17, 2023
Enrollment
94 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis